BioSpace News Archive

Business

David F. Melbourne Jr. Promoted to Chief Executive Officer of AquaBounty; Sylvia Wulf to Continue as Non-Executive Board Chair

The Board of Directors of AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability

June 7, 2024
·
8 min read
NervGen Pharma Grants Stock Options.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that the company has granted 950,000

June 7, 2024
·
1 min read
Biotech Bay

BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress

BioMarin Pharmaceutical Inc. will be presented at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Bangkok, Thailand, June 22-26, 2024.

June 7, 2024
·
15 min read
Biotech Beach

ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update

ImmunityBio, Inc. ( NASDAQ: IBRX ) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time.

June 7, 2024
·
6 min read
Biotech Beach

Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference

Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference.

June 7, 2024
·
7 min read
Deals

Octane Medical acquires B. Braun’s global orthobiologics business

Octane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global

June 7, 2024
·
4 min read
Biotech Beach

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024

Puma Biotechnology, Inc., a biopharmaceutical company, announced that on June 6, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering 3,500 shares of Puma common stock to one new non-executive employee.

June 7, 2024
·
2 min read
FDA

US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk

GSK plc announced that the US Food and Drug Administration has approved AREXVY Vaccine, Adjuvanted) for the prevention of RSV lower respiratory tract disease in adults 50 through 59 years of age who are at increased risk.

June 7, 2024
·
8 min read
Alvotech Announces Strategic Refinancing Agreement - June 07, 2024

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced the successful arrangement of a strategic refinancing transaction.

June 7, 2024
·
9 min read
Policy

FDA Clears Portable Blood & IV-Fluid Warmer System From Danish Medtech Company °MEQU

, Danish MedTech company, °MEQU announces 510 regulatory clearance from the U.S. Food and Drug Administration of the °M Warmer System - a portable blood & IV fluid warmer system for military and civilian use.

June 7, 2024
·
2 min read